Psychopharmacology

, Volume 113, Issue 2, pp 225–230 | Cite as

Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram

  • Alex L. van Bemmel
  • Rutger H. van den Hoofdakker
  • Domien G. M. Beersma
  • Antoinette L. Bouhuys
Original Investigations

Abstract

Drug-induced improvement of depression may be mediated by changes in sleep physiology. The aim of this study was to relate changes in sleep polygraphic variables to clinical state during treatment with citalopram, a highly specific serotonin uptake inhibitor. Sixteen patients took part. The study was single-blind and uncontrolled. A 1-week wash-out period was followed by 1 week of placebo administration, a medication period of 5 weeks, and a 1-week placebo period. For the entire group a significant decrease of rapid eye movement sleep (REMS) and a significant lengthening of REMS latency were observed initially as well as at the end of treatment. No changes in sleep continuity were found, but non-REMS stage 2 (percentage) was significantly increased. On the basis of clinical change, as expressed by the scores of the Hamilton Rating Scale for Depression, at the end of the citalopram treatment the patient group was split in two halves: eight less and eight more improved patients. The groups did not differ with respect to any sleep polygraphic varible.

Key words

Depression Polysomnography Antidepressants Citalopram 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Psychiatric Association: Diagnostic and statistical manual of mental disorders (DSM-III-R) (1987), 3rd revised edn. APA, Washington DCGoogle Scholar
  2. Bech P, Cialdella P (1992) Citalopram, meta-analysis of intended and unintended effects. Int Clin Psychopharmacol 6[Suppl 5]:45–54Google Scholar
  3. Beersma DGM, van den Hoofdakker RH (1992) Can non-REM sleep be depressogenic? J Affect Dis 24: 101–108Google Scholar
  4. Borbély AA, Wirz-Justice A (1982) Sleep, sleep deprivation and depression: a hypothesis derived from a model of sleep regulation. Hum Neurobiol 1:205–210Google Scholar
  5. Borbély AA, Baumann F, Brandeis D, Strauch I, Lehmann D (1981) Sleep deprivation: effect on sleep stages and EEG power density in man. Electroencephalogr Clin Neurophysiol 51:483–493Google Scholar
  6. Elsenga, S (1988) Een zelfbeoordelingsschaal voor depressie. T v Psychiatrie 30:114–126Google Scholar
  7. Gillin JC, Wyatt RJ, Fram D, Snyder F (1978) The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology 59:267–272Google Scholar
  8. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychiatry 16:278–296Google Scholar
  9. Hilakivi I, Kovala T, Leppävuori A, Shvaloff A (1987) Effects of serotonin and noradrenaline uptake blockers on wakefulness and sleep in cats. Pharmacol Toxicol 60:161–166Google Scholar
  10. Hyttel J (1982) Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepresant activity. Prog Neuropsychopharmacol Biol Psychiatry 6:277–295Google Scholar
  11. Kupfer DJ, Spiker DG, Coble PA, Neil JF, Ulrich R, Shaw DH (1981) Sleep and treatment prediction in endogenous depression. Am J Psychiatry 138:429–434Google Scholar
  12. Leibenluft E, Wehr TA (1992) Is sleep deprivation useful in the treatment of depression? Am J Psychiatry 149:159–168Google Scholar
  13. Mendelson WB (1989) Pharmacology of slow wave sleep in illness and health. In: Wauquier A, Dogovic L, Radulovacki M (eds) Slow wave sleep: physiological, pathophysiolocal and functional aspects. Raven, New York, pp 155–165Google Scholar
  14. Mulder-Hajonides van der Meulen WREH (1981) Measurement of subjective sleep quality. In: Proceedings of the European Sleep Congress, Amsterdam, The NetherlandsGoogle Scholar
  15. Nicholson AN, Bradley CM, Pascoe PE (1989) Medications: effect on sleep and wakefulness. In: Kryger M, Roth T, Dement W (eds) Principles and practice of sleep medicine. WB Saunders, Philadelphia, pp 228–236Google Scholar
  16. O'Brien RG, Kister Kaiser M (1985) MANOVA method for analyzing repeated measures designs: an extensive primer. Psychol Bull 97:316–333Google Scholar
  17. Oswald I (1973) Sleep studies with clomipramine (Anafranil) and related drugs. J Int Med Res 1:296–298Google Scholar
  18. Overo KF (1982) Kinetics of citalopram in man: plasma levels in patients. Prog Neuropsychopharmacol Biol Psychiatry 6:311–318Google Scholar
  19. Oyehaug E, Ostensen ET (1984) High-performance liquid chromatographic determination of citalopram and four of its metabolites in plasma and urine samples from psychiatric patients. J Chromatogr 308:199–208Google Scholar
  20. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. UCLA Brain Information Service Institute, Los Angeles.Google Scholar
  21. Riemann D, Berger M (1990) The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder. Acta Psychiatr Scand 81:24–31Google Scholar
  22. Van Bemmel AL, Havermans AG, van Diest R (1992) Effects of trazodone on EEG sleep and clinical state in major depression. Psychopharmacology 107:569–574Google Scholar
  23. Vogel GW, Thurmond A, Gibbons P, Sloan K, Bouyd M, Walker M (1975) REM sleep reduction effects on depression syndromes. Arch Gen Psychiatry 32:765–777Google Scholar
  24. Vogel GW, Vogel F, McAbee RS, Hennessey A (1980) Improvement of depression by REM sleep deprivation: new findings and a theory. Arch Gen Psychiatry 37:247–253Google Scholar
  25. Vogel GW, Buffenstein A, Minter K, Hennessey A (1990) Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev 14:49–63Google Scholar
  26. Zerssen D von (1976) Die Befindlichkeitsskala. Manual. Beltz, WeinheimGoogle Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • Alex L. van Bemmel
    • 1
  • Rutger H. van den Hoofdakker
    • 2
  • Domien G. M. Beersma
    • 2
  • Antoinette L. Bouhuys
    • 2
  1. 1.Academic Mood Disorders Clinic and Sleep Laboratory, Department of PsychiatryUniversity of LimburgMaastrichtThe Netherlands
  2. 2.Department of Biological PsychiatryUniversity of GroningenThe Netherlands

Personalised recommendations